Results
1
Undervalued Small Caps
1 companies
Newron Pharmaceuticals
Market Cap: CHF 472.1m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 23.65
7D
3.3%
1Y
168.1%
